Information  X 
Enter a valid email address

Primary Health Props (PHP)

  Print      Mail a friend

Thursday 16 January, 2020

Primary Health Props

Scrip Dividend Reference Price

RNS Number : 0524A
Primary Health Properties PLC
16 January 2020
 

 

 

Primary Health Properties PLC

(the "Company")

 

Scrip Dividend Scheme

 

The Company announces that the scrip dividend reference price for the First Quarterly Interim Dividend in 2020 (the "Interim Dividend"), payable on 21 February 2020, is 158.20 pence.  

 

The reference price is the price at which Primary Health Properties PLC ordinary shares of 12.5p each ("Ordinary shares") will be issued to shareholders who have elected to receive shares in lieu of cash dividends through participation in the Scrip Dividend Scheme and is the average of the closing middle market quotations of the Ordinary shares derived from the London Stock Exchange Daily Official List for the day on which the Ordinary shares were first quoted as ex-dividend (9 January 2020) and the four subsequent dealing days (being 10,13,14 and 15 October 2020).

 

Any shareholders entitled to the Interim Dividend who do not already participate in the Scrip Dividend Scheme (or whose mandates are not deemed valid and effective, as explained above) and wish to do so, may obtain a mandate form either by contacting the Company's Registrar, Equiniti, on 0871 384 2268, or by downloading from the Company's website www.phpgroup.co.uk/Investors, or from the National Storage Mechanism. This form must be completed and returned to Equiniti to arrive no later than the close of business on 7 February 2020 in order for it to be effective for the Interim Dividend.

 

 

Contacts:

 

Paul Wright, for Nexus Management Services Limited, Secretary

Telephone: 020 7451 7050

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DIVUNAARRAUAAAR

a d v e r t i s e m e n t